ACEBOT-SP

Aceclofenac 100 MG + Paracetamol 325 MG + Serratiopeptidase 15 MG

ACEBOT-SP Tablet Details

The brand name of  Aceclofenac Paracetamol Serratiopeptidase tablet presented by Creogenic Pharma is Acebot-SP. Below mentioned are some of the details about this product.

  • Composition of Product: Aceclofenac 100mg + Paracetamol 325mg + Serratiopeptidase 15mg
  • Marketed By: Creogenic Pharma
  • Prescription Required: Yes, as it belongs to Schedule ‘H’
  • Form: Tablet, Syrup
  • Shelf Life/Expiry: 2 Years or 24 months from the date of manufacturing
  • Type of Drug: NSAID + Analgesic + Antipyretic

SEND ENQUIRY

    What is Aceclofenac Paracetamol Serratiopeptidase Tablet?

    Aceclofenac Paracetamol Serratiopeptidase Tablet is an Anti-Inflammatory drug that is used to treat patients with signs of redness, swelling, pain, fever, and other inflammations.

    How Aceclofenac Paracetamol Works?

    Aceclofenac is a Non-Steroidal Anti Inflammatory (NSAID) drug. This drug Aceclofenac with a combination of Paracetamol works by blocking the action of chemical messengers which are responsible for the cause of pain, swelling, redness, etc. This combination works by inhibiting the Cyclo Oxygenase Enzymes which further block prostaglandin secretion and Serratiopeptidase is a proteolytic enzyme having anti-inflammatory and antipyretic properties.

    Aceclofenac Paracetamol Serratiopeptidase Dosage?

    The Dosage of Aceclofenac Paracetamol Serratiopeptidase should be decided by a physician for every patient depending on various factors such as Age, Weight, Mental Status, Allergic History, etc. of the patient.

    It is not recommended for use of Aceclofenac Paracetamol in children without the guidance of a Pediatric Consultant.

    Dose alteration should only be administered as per the guidance of the Physician.

    How Aceclofenac Paracetamol Works

    What is Aceclofenac Paracetamol Syrup

    Aceclofenac Paracetamol Chlorzoxazone

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    Post comment